Maria Paramo Alfaro MD, Presenter: Nothing to Disclose

Jose Maria Bondia MD, Abstract Co-Author: Nothing to Disclose

Romina Zalazar MD, Abstract Co-Author: Nothing to Disclose

Damaso Aquerreta, Abstract Co-Author: Nothing to Disclose

Maite Millor MEd, Abstract Co-Author: Nothing to Disclose

Paula Barquin Garcia MD, Abstract Co-Author: Nothing to Disclose

Lidia Sancho Rodriguez, Abstract Co-Author: Nothing to Disclose

1.- To define the Durie-Salmon criteria for staging Multiple Myeloma (MM)  2.- To review the Durie- Salmon PLUS criteria  3.- To analize the advantages and disadvantages of different imaging techniques    3.1- Plain radiography    3.2- Computed Tomography (CT)    3.3- Low dose CT (LDCT)    3.4- MRI    3.5- PET-CT 4.- Implications of MRI and PET-CT in the prognosis of MM 5.- Controversial aspects in recent guidelines: LDCT vs MRI vs PET-CT for MM detection, staging and prognosis

1. MM definition 2. MM laboratory data 3. Imaging techniques   - Morphological techniques: advantages and disadvantages        Plain radiography, CT, LDCT, MRI   - Morpho-functional techniques: advantages and disadvantages       MRI (diffusion) and 18FDG PET-CT 4. Implications of MRI and PET-CT in the prognosis of MM 5. LDCT or MRI or PET-CT for MM detection and prognosis? Controversial aspects 6. Future directions and summary

http://abstract.rsna.org/uploads/2014/14009444/14009444_itih.pdf

Paramo Alfaro, M, Bondia, J, Zalazar, R, Aquerreta, D, Millor, M, Garcia, P, Sancho Rodriguez, L, Imaging techniques in Diagnosis and Prognosis of Multiple Myeloma: Which Will Win the Battle?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14009444.html